Compare MLAB & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MLAB | LAB |
|---|---|---|
| Founded | 1982 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 461.9M | 354.1M |
| IPO Year | 1995 | 2008 |
| Metric | MLAB | LAB |
|---|---|---|
| Price | $99.12 | $0.89 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 1 |
| Target Price | ★ $94.00 | $1.35 |
| AVG Volume (30 Days) | 89.6K | ★ 2.0M |
| Earning Date | 05-27-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.65% | N/A |
| EPS Growth | ★ 99.24 | 61.54 |
| EPS | ★ 1.95 | N/A |
| Revenue | N/A | ★ $101,937,000.00 |
| Revenue This Year | $6.07 | N/A |
| Revenue Next Year | $5.41 | $2.63 |
| P/E Ratio | $50.18 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $59.63 | $0.87 |
| 52 Week High | $128.55 | $1.72 |
| Indicator | MLAB | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 69.20 | 35.40 |
| Support Level | $69.02 | N/A |
| Resistance Level | $103.73 | $1.39 |
| Average True Range (ATR) | 3.73 | 0.04 |
| MACD | 1.49 | 0.01 |
| Stochastic Oscillator | 88.02 | 18.13 |
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.